Seres Therapeutics (MCRB) announces the receipt of a $50M installment payment related to the Company’s previously announced sale of its VOWST business to Societe des Produits Nestle S.A. This installment payment was expected as Seres is fulfilling its transition obligations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCRB:
- Seres Therapeutics Strengthens Future with VOWST Sale
- Seres announces new translational biomarker results from SER-155 Phase 1b study
- Xilio Therapeutics appoints Caroline Hensley as CLO
- Seres Therapeutics to highlight plans for SER-155 at JPMorgan conference
- Biotech Alert: Searches spiking for these stocks today